Skip to main content

Calgary Canadian Pacific Ltd. said Tuesday it is selling off a pair of landmark Canadian hotels for $305-million.

CP's hotel and resort unit said it has signed a deal with Legacy Hotels Real Estate Investment Trust to buy Le Chateau Frontenac in Quebec City and Victoria, B.C.'s The Empress hotel.

Legacy will pay $185-million for the 607-room Quebec hotel and $120-million for the Victoria property, which was built in 1908 and has 472 rooms.

Story continues below advertisement

"With the sale of The Empress and Le Chateau Frontenac to the Legacy REIT, we are able to realize the value of some of our real estate assets while maintaining long-term management contracts at these premier properties," David O'Brien, CP's president and chief executive, said.

"Over the past three years, we have significantly expanded our hotel business and will continue to look at opportunities to grow both within North America and internationally."

CP has owned the two hotels since they were built. Both are managed by luxury hotel management firm Fairmont Hotels and Resorts, of which CP controls 67 per cent.

Under Tuesday's deal, the two hotels will be acquired by a Legacy subsidiary, which will issue exchangeable shares to Canadian Pacific Hotel and Resorts Inc. worth about $120-million. The balance of the purchase price will be paid in cash.

The sale is expected to close in December.



Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter